Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Viral decay kinetics during induction therapy with or without the use of enfuvirtide in HAART [highly-active antiretroviral]-naive patients with advanced HIV

Trial Profile

Viral decay kinetics during induction therapy with or without the use of enfuvirtide in HAART [highly-active antiretroviral]-naive patients with advanced HIV

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Feb 2013

At a glance

  • Drugs Enfuvirtide (Primary) ; Efavirenz; Lamivudine; Tenofovir
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Jun 2007 Status change from recruiting to completed.
    • 07 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top